CN104055117A - 一种含有花生四烯酸的海狗油软胶囊 - Google Patents
一种含有花生四烯酸的海狗油软胶囊 Download PDFInfo
- Publication number
- CN104055117A CN104055117A CN201410297615.5A CN201410297615A CN104055117A CN 104055117 A CN104055117 A CN 104055117A CN 201410297615 A CN201410297615 A CN 201410297615A CN 104055117 A CN104055117 A CN 104055117A
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- seal oil
- acid
- brain
- dha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 title claims abstract description 24
- 235000021342 arachidonic acid Nutrition 0.000 title claims abstract description 12
- 229940114079 arachidonic acid Drugs 0.000 title claims abstract description 12
- 239000007901 soft capsule Substances 0.000 title claims abstract description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims abstract description 12
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 7
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 7
- 229940046009 vitamin E Drugs 0.000 claims abstract description 7
- 239000011709 vitamin E Substances 0.000 claims abstract description 7
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims abstract description 6
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims abstract description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000010445 lecithin Nutrition 0.000 claims abstract description 6
- 229940067606 lecithin Drugs 0.000 claims abstract description 6
- 239000000787 lecithin Substances 0.000 claims abstract description 6
- 229940031439 squalene Drugs 0.000 claims abstract description 6
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims abstract description 6
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 5
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract description 5
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims abstract description 3
- 239000002775 capsule Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- PIFPCDRPHCQLSJ-WYIJOVFWSA-N 4,8,12,15,19-Docosapentaenoic acid Chemical compound CC\C=C\CC\C=C\C\C=C\CC\C=C\CC\C=C\CCC(O)=O PIFPCDRPHCQLSJ-WYIJOVFWSA-N 0.000 claims description 2
- PIFPCDRPHCQLSJ-UHFFFAOYSA-N Clupanodonic acid Natural products CCC=CCCC=CCC=CCCC=CCCC=CCCC(O)=O PIFPCDRPHCQLSJ-UHFFFAOYSA-N 0.000 claims description 2
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 claims description 2
- 235000021290 n-3 DPA Nutrition 0.000 claims description 2
- 210000004556 brain Anatomy 0.000 abstract description 13
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 abstract description 9
- 230000006870 function Effects 0.000 abstract description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 7
- 208000024827 Alzheimer disease Diseases 0.000 abstract description 5
- 206010039966 Senile dementia Diseases 0.000 abstract description 5
- 235000021294 Docosapentaenoic acid Nutrition 0.000 abstract description 4
- 108010010803 Gelatin Proteins 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 230000002490 cerebral effect Effects 0.000 abstract description 4
- 229920000159 gelatin Polymers 0.000 abstract description 4
- 239000008273 gelatin Substances 0.000 abstract description 4
- 235000019322 gelatine Nutrition 0.000 abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 6
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 3
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 3
- 235000015097 nutrients Nutrition 0.000 abstract 2
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000015015 brainstem development Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000008271 nervous system development Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000196 olfactory nerve Anatomy 0.000 description 1
- 230000019240 optic nerve development Effects 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000004243 retinal function Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明提供了一种含有花生四烯酸的海狗油软胶囊，主要有效成分是：海狗油[含有EPA（二十碳五烯酸）、DHA（二十二碳六烯酸）、DPA（二十二碳五烯酸）、角鲨烯]、花生四烯酸[AA（二十碳四烯酸）]油、卵磷脂[PC(磷脂酰胆碱）]、维生素E，主要辅料为水、甘油和食用动物明胶。该海狗油软胶囊将具有改善心脑血管功能的有效成分：DPA、EPA和对大脑生长、发育具有重要作用的营养物质：DHA、AA和PC有效结合在一起，成分之间进一步协同作用，在改善人体心脑血管循环功能的基础上，更好地为大脑提供营养，具有改善记忆力、消除大脑疲劳、预防老年痴呆的作用。
Description
（一）技术领域
本发明涉及一种海狗油软胶囊，尤其是一种含有花生四烯酸的海狗油软胶囊，属于保健食品技术领域。
（二）背景技术
目前，随着生活水平的不断提高，人们对高脂肪肉类食品的摄入量不断增加，伴随而来的是血液中脂肪含量的不断升高，并且由此引起的动脉血管硬化、血栓、冠心病等疾病。由于血液循环不畅，大脑活动所需的营养物质不能及时供应，有些人会出现头晕头痛、失眠健忘、记忆力衰退等症状；特别是一些老年人，随着身体各个器官的老化，记忆力衰退更加严重，甚至影响正常的生活，导致老年痴呆。这些人们迫切需要一种既能改善血液循环、又能尽快补充大脑营养的保健品。
（三）发明内容
本发明为了弥补现有技术的不足，提供了一种含有花生四烯酸的海狗油软胶囊，主要有效成分是：海狗油[含有EPA（二十碳五烯酸）、DHA（二十二碳六烯酸）、DPA（二十二碳五烯酸）、角鲨烯]、花生四烯酸 [AA（二十碳四烯酸）] 油、卵磷脂[PC(磷脂酰胆碱）]、维生素E，主要辅料为水、甘油和食用动物明胶。
海狗油中EPA：俗称“血管清道夫”，具有防止血管硬化、心脑血管栓塞，降低高血压、高血脂及胆固醇，抑制血小板凝聚等作用。DHA：俗称“脑黄金”，是脑组织和视神经发育及功能发挥所必须的营养物质。可用于增强记忆力，促进婴幼儿智力开发及提高智商，预防和治疗老年痴呆症。DPA：可促进和提高人体的免疫力。对糖尿病、类风湿性关节炎、牛皮癣、气喘病，溃疡性大小肠炎等均有治疗作用。角鲨烯：天然抗氧化剂。有助于防癌和抗癌及滋润皮肤使其光滑而富弹性。
花生四烯酸(AA)对婴幼儿大脑和视网膜功能的完善具有重要意义，AA的缺乏对于人体组织器官的发育,尤其是大脑和神经系统发育会产生严重不良影响。成人长期缺乏，也会影响大脑的功能，导致记忆力衰退及老年痴呆的发生。
卵磷脂(PC)能为大脑神经细胞提供充足的养料，使脑神经之间的信息传递速度加快，从而提高大脑活力，消除大脑疲劳，使大脑思维敏捷，提高学习和工作效率。卵磷脂在修复受损伤脑细胞、打通大脑与血液循环之间障碍的同时，可维持脑神经细胞的正常功能，并增强大脑神经系统功能，具有预防大脑功能衰退的功效。
维生素E能够保护高度不饱和脂肪酸（DHA、AA、DPA、EPA）不被氧化，延长产品保质期。
本发明的有益效果是：该海狗油软胶囊将具有改善心脑血管功能的有效成分：DPA、EPA和对大脑生长、发育具有重要作用的营养物质DHA、AA和PC，各成分之间进一步协同作用，在改善心脑血管循环功能的基础上，为大脑提供充足的营养，具有改善记忆力、消除大脑疲劳、预防老年痴呆的作用。
（四）具体实施方式
1、配制内容物：将原材料海狗油、花生四烯酸油、卵磷脂、维生素E按照一定的配方混合到一起，搅拌均匀，内容物功效成分净含量的质量百分比为EPA：8～10%、DHA：10～15%、DPA：5~10%、AA：10～15%、角鲨烯2~5%、PC：2~5%，其余成分为1%的维生素E和海狗油中的其它非功效成分。
2、制作胶囊体材料：以食用明胶、甘油和纯净水为囊体原料，将甘油和纯净水按照比例注入溶胶罐内，加热搅拌至75℃左右，再加入明胶，继续搅拌20～30分钟后真空脱泡，制作得到囊体材料。
3、将配好的内容物和胶囊体经过压丸、成型、洗丸、干燥，制成成品海狗油软胶囊。
Claims (2)
1. 一种含有花生四烯酸的海狗油软胶囊，其特征在于：胶囊内容物原料的质量百分比为海狗油[含有EPA（二十碳五烯酸）、DHA（二十二碳六烯酸）、DPA（二十二碳五烯酸）、角鲨烯]：55～65% 、花生四烯酸 [AA（二十碳四烯酸）] 油：25～35% 、卵磷脂[PC(磷脂酰胆碱）]：5～15%、维生素E：1% 。
2.根据权利要求1所述的一种含有花生四烯酸的海狗油软胶囊，其特征在于：胶囊内容物功效成分的质量百分比为EPA：8～10%、DHA：10～15%、DPA：5~10%、AA：10～15%、角鲨烯2~5%、PC：2~5%，其余成分为1%的维生素E和海狗油中的其它非功效成分。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410297615.5A CN104055117A (zh) | 2014-06-29 | 2014-06-29 | 一种含有花生四烯酸的海狗油软胶囊 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410297615.5A CN104055117A (zh) | 2014-06-29 | 2014-06-29 | 一种含有花生四烯酸的海狗油软胶囊 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104055117A true CN104055117A (zh) | 2014-09-24 |
Family
ID=51543275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410297615.5A Pending CN104055117A (zh) | 2014-06-29 | 2014-06-29 | 一种含有花生四烯酸的海狗油软胶囊 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104055117A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113519848A (zh) * | 2021-07-28 | 2021-10-22 | 宁波天皓生物科技有限公司 | 一种dha藻油与ara组合物制品加工方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810336A (zh) * | 2010-04-30 | 2010-08-25 | 广东仙乐制药有限公司 | 一种咀嚼性软胶囊及其制备方法 |
| CN103371984A (zh) * | 2012-04-28 | 2013-10-30 | 芜湖中加生物制药股份有限公司 | 海狗油ω-3多不饱和脂肪酸胶丸 |
| CN103800435A (zh) * | 2014-02-12 | 2014-05-21 | 山东天地健生物工程有限公司 | 一种海狗油软胶囊 |
-
2014
- 2014-06-29 CN CN201410297615.5A patent/CN104055117A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810336A (zh) * | 2010-04-30 | 2010-08-25 | 广东仙乐制药有限公司 | 一种咀嚼性软胶囊及其制备方法 |
| CN103371984A (zh) * | 2012-04-28 | 2013-10-30 | 芜湖中加生物制药股份有限公司 | 海狗油ω-3多不饱和脂肪酸胶丸 |
| CN103800435A (zh) * | 2014-02-12 | 2014-05-21 | 山东天地健生物工程有限公司 | 一种海狗油软胶囊 |
Non-Patent Citations (1)
| Title |
|---|
| 李湛军等: "海狗油ω-3脂肪酸的研究进展及作用机制", 《药物分析杂志》, vol. 24, no. 5, 31 December 2004 (2004-12-31), pages 561 - 567 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113519848A (zh) * | 2021-07-28 | 2021-10-22 | 宁波天皓生物科技有限公司 | 一种dha藻油与ara组合物制品加工方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102422907B (zh) | 一种健脑益智调和油 | |
| CN109337939B (zh) | 一种多不饱和脂肪酸结构脂质的制备方法 | |
| CN101720822A (zh) | 一种脂肪酸组分平衡并含有活性成分的中老年型营养调和油 | |
| CN104082751A (zh) | 一种含有虾青素的深海鱼油软胶囊 | |
| AU2020102055A4 (en) | Brain-building gel candy and preparation method thereof | |
| CN108835262A (zh) | 一种改善记忆力的调制乳粉及其制备方法 | |
| CN104351358A (zh) | 一种健脑改善记忆的保健食品 | |
| CN107683908A (zh) | α‑亚麻酸和神经酸营养强化菜籽油及其制备方法和应用 | |
| CN105918497A (zh) | 具有保健功能的调和油及其制备方法 | |
| CN103989181A (zh) | 核桃油鱼油软胶囊 | |
| CN103989184A (zh) | 一种含有花生四烯酸的藻油软胶囊 | |
| CN104000208A (zh) | 一种含有角鲨烯的深海鱼油软胶囊 | |
| CN108651635A (zh) | 具有健脑补脑功效的营养均衡的健康食用油 | |
| RU2005130342A (ru) | Комбинация активных ингредиентов масел, содержащих w3-жирные кислоты, с растительными экстрактами, содержащими полифенолы, и их применение | |
| CN1108891A (zh) | 含多不饱和脂肪酸的强化牛奶 | |
| CN108902719A (zh) | 一种保健面条及其制备方法 | |
| CN104055117A (zh) | 一种含有花生四烯酸的海狗油软胶囊 | |
| CN103989180B (zh) | 含有丹参提取物的深海鱼油软胶囊 | |
| CN104187727A (zh) | 含有丹参提取物的海狗油软胶囊 | |
| CN104187676A (zh) | 含有葛根提取物的海狗油软胶囊 | |
| CN103948084A (zh) | 一种鱼油马兰头补脑核桃花生酱 | |
| CN103535729A (zh) | 西洋参提取物、大鲵提取物的混合保健食品 | |
| CN104172151A (zh) | 一种含有辅酶q10的海狗油软胶囊 | |
| CN104082741A (zh) | 一种含有虾青素的海狗油软胶囊 | |
| CN106332982A (zh) | 一种食用调和油及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140924 |